COCH

Envoy Medical Inc

0.5959

Oct 22 • 3:59 PM ET -0.0512 (-7.91%)

0.5900

Aftermarket • 4:15 PM ET -0.0059 (-0.99%)

Healthcare Medical Devices USA Nano NASD

Today, 8:35 AMEnvoy Medical announces 1-for-10 reverse stock split of its Class A common stock effective October 26, 2026 to help maintain Nasdaq listing compliance.

Peers: CVRX NPCE INSP NYXH ECOR LIVN NMTC PHG IRIX MODD

| Held by: VXF VTI

Scroll to Statements

Index	-
Market Cap	46.12M
Enterprise Value	27.25M
Income	-28.46M
Sales	0.21M
Book/sh	0.04
Cash/sh	0.25
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	43
IPO	Apr 29, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	219.61
P/B	13.93
P/C	2.34
P/FCF	-
EV/EBITDA	-
EV/Sales	129.75
Quick Ratio	1.61
Current Ratio	1.73
Debt/Eq	0.25
LT Debt/Eq	0.21
Option/Short	No / Yes

EPS (ttm)	-0.77
EPS next Y	-0.24
EPS next Q	-0.07
EPS this Y	76.69%
EPS next Y	17.44%
EPS next 5Y	42.00%
EPS past 3/5Y	7.81% -
Sales past 3/5Y	0.56% -
EPS Y/Y TTM	42.70%
Sales Y/Y TTM	-6.76%
EPS Q/Q	78.47%
Sales Q/Q	-34.62%
Earnings	Aug 10 BMO
EPS/Sales Surpr.	12.50% 2.00%

Insider Own	40.23%
Insider Trans	0.00%
Inst Own	23.10%
Inst Trans	2.10%
ROA	-138.27%
ROE	-
ROIC	-587.82%
Gross Margin	-385.51%
Oper. Margin	-11411.11%
Profit Margin	-13747.34%
SMA20	-9.71%
SMA50	-14.71%
SMA200	-13.43%
Trades

Shs Outstand	77.19M
Shs Float	46.26M
Short Float	1.08%
Short Ratio	5.63
Short Interest	0.50M
52W High	0.95 -37.53%
52W Low	0.36 64.39%
Volatility	6.99% 5.07%
ATR (14)	0.04
RSI (14)	33.87
Beta	2.01
Rel Volume	2.20
Avg Volume	88.40K
Volume	194,425

Perf Week	-7.57%
Perf Month	-17.47%
Perf Quarter	-10.08%
Perf Half Y	-13.64%
Perf YTD	-9.86%
Perf Year	-25.49%
Perf 3Y	-64.32%
Perf 5Y	-93.88%
Perf 10Y	-
Recom	1.00
Target Price	2.17
Prev Close	0.65
Price	0.60
Change %	-7.91%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-06-26	Initiated	Lake Street	Buy	$2.50
Mar-31-26	Initiated	H.C. Wainwright	Buy	$2.50
Jun-24-24	Initiated	Ascendiant Capital Markets	Buy	$8.50

Today 08:30AM	Envoy Medical Announces Reverse Stock Split (Newsfile Corp.) -7.91%
Oct-20-26 08:30AM	Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design (Newsfile)
Oct-12-26 08:30AM	Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant (Newsfile Corp.)
Sep-22-26 08:30AM	Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio (Newsfile)
Sep-02-26 08:30AM	Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th (Newsfile)
08:00AM	Loading…
Aug-10-26 08:00AM	Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones (Newsfile) +5.04%
Jul-21-26 09:17AM	Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial (Newsfile)
Jul-14-26 09:17AM	Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant (Newsfile) +9.37%
Jun-30-26 08:30AM	Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device (Newsfile) +15.96%
Jun-25-26 08:30AM	Envoy Medical Terminates At-the-Market (ATM) Equity Facility (Newsfile) +6.66%
Jun-18-26 08:30AM	Envoy Medical to Present at Investor Conferences on June 25th (Newsfile)
Jun-04-26 08:30AM	Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th (Newsfile)
May-20-26 08:30AM	Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology (Newsfile)
May-11-26 08:00AM	Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant (Newsfile)
Apr-28-26 08:30AM	Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant (Newsfile)
08:00AM	Loading…
Apr-22-26 08:00AM	Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant (Newsfile)
Apr-16-26 08:00AM	Envoy Medical Appoints Chas McKhann to Board of Directors (Newsfile)
Apr-01-26 08:00AM	Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant (Newsfile) +6.00%
Mar-23-26 08:30AM	Envoy Medical Reports Full Year 2025 Financial Results (Newsfile)
Mar-11-26 08:00AM	Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant (Newsfile) +9.08%
Feb-24-26 08:00AM	Envoy Medical Regains Compliance with Nasdaq Listing Requirement (Newsfile) +6.74%
Feb-23-26 08:00AM	Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space (Newsfile)
Feb-19-26 08:00AM	Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial (Newsfile)
Feb-17-26 08:00AM	Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant (Newsfile) +14.82%
Feb-12-26 04:05PM	Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering (Newsfile Corp.) -20.52% +14.44%
Feb-11-26 09:25AM	Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering (Newsfile Corp.) +69.20%
Dec-18-25 08:00AM	Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant (Newsfile)
Dec-16-25 08:00AM	Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio (Newsfile)
Dec-10-25 08:00AM	Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant (Newsfile)
Dec-04-25 08:00AM	Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient (Newsfile)
12:00PM	Loading…
Dec-03-25 12:00PM	Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why (Zacks)
Dec-02-25 08:00AM	Envoy Medical Announces the Grant of Its 40th U.S. Patent (Newsfile)
Nov-20-25 08:00AM	Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery (Newsfile)
Nov-18-25 08:00AM	Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial (Newsfile) +17.48%
Nov-10-25 09:40AM	Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Envoy Medical Reports Third Quarter 2025 Financial and Operational Results (Newsfile)
Nov-06-25 06:15PM	ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
10:00AM	Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Nov-05-25 08:15AM	Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-04-25 09:15AM	Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates (Zacks) -5.04%
08:00AM	Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial (Newsfile)
Oct-29-25 08:00AM	Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant (Newsfile)
Oct-28-25 05:15PM	OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Oct-27-25 08:00AM	Envoy Medical Receives Positive Listing Determination from NASDAQ (Newsfile)
Oct-20-25 09:55AM	Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' Now (Zacks)
Oct-09-25 04:05PM	Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Newsfile) -6.75%
Oct-08-25 07:00AM	Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Newsfile) -41.50%
07:00AM	Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates (Newsfile)
Oct-07-25 08:00AM	Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data (Newsfile) +97.07%
07:46AM	EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial (Benzinga)
Oct-01-25 08:00AM	Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th (Newsfile)
Sep-25-25 08:00AM	Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Newsfile)
Sep-24-25 08:00AM	Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track (Newsfile)
Sep-22-25 08:00AM	Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Newsfile) -27.90%
Sep-19-25 08:00AM	Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology (Newsfile)
Sep-10-25 08:00AM	Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments (Newsfile)
Sep-09-25 08:00AM	Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology (Newsfile)
Sep-08-25 08:00AM	Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025 (Newsfile)
Sep-03-25 08:00AM	Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant (Newsfile)
Aug-26-25 08:00AM	Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board (Newsfile)
07:46AM	EXCLUSIVE: Envoy Medical Retires $32 Million Debt, Glen Taylor Steps Down From Board After Two Decades (Benzinga)
Aug-20-25 08:00AM	Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology (Newsfile)
Jul-31-25 10:30AM	Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.22%
08:00AM	Envoy Medical Reports on Second Quarter 2025 Results (Newsfile)
Jul-15-25 04:58PM	Envoy Medical Draws Final $5 Million From GAT Funding (Insider Monkey) +5.13%
Jul-08-25 08:00AM	Envoy Medical Expands Patent Portfolio with New Issuances in the United States (Newsfile)
Jul-01-25 08:00AM	Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia (Newsfile)
Jun-26-25 08:00AM	New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical (Newsfile)
Jun-13-25 08:35AM	Life Sciences Investor Forum: Now Available for Online Viewing (GlobeNewswire)
Jun-11-25 08:30AM	Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th (GlobeNewswire)
Jun-10-25 02:38PM	Life Sciences Investor Forum Agenda Announced for June 11th-12th (GlobeNewswire)
08:30AM	Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up (Newsfile)
May-13-25 09:15AM	Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial (Newsfile)
May-01-25 12:30PM	Envoy Medical Reports on First Quarter 2025 Results (Newsfile)
Apr-22-25 06:00AM	EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies (GlobeNewswire) +6.87%
Mar-31-25 09:15AM	Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results (Newsfile)
Mar-17-25 09:25AM	Hearing Device Coverage Clarification Act Reintroduced in House and Senate (Newsfile) +6.99%
Mar-12-25 09:00AM	Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device (Newsfile) +8.89%
Mar-10-25 09:00AM	Envoy Medical to Participate in the 37th Annual ROTH Conference (Newsfile)
Feb-24-25 09:25AM	First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant (Newsfile)
Feb-14-25 09:15AM	Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio (Newsfile)
Dec-19-24 09:00AM	Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study (Newsfile) +7.60%
Dec-16-24 09:00AM	Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss (GlobeNewswire) -10.20%
Nov-14-24 08:38AM	Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events (GlobeNewswire) +8.67%
Nov-12-24 09:25AM	Envoy Medical's Fully Implanted Acclaim Cochlear Implant Highlighted in Peer-Reviewed Publication (GlobeNewswire)
Nov-08-24 09:25AM	Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System (GlobeNewswire)
Nov-01-24 08:00AM	Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device (GlobeNewswire)
Oct-24-24 08:00AM	Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage (GlobeNewswire)
Oct-23-24 08:00AM	Envoy Medical to Present at the LD Micro Main Event XVII (GlobeNewswire) -5.86%
Oct-22-24 08:00AM	American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical's Esteem Device (GlobeNewswire)
Oct-01-24 08:00AM	Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market (GlobeNewswire) -17.85%
Sep-23-24 08:00AM	Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company (GlobeNewswire) +6.29%
Sep-16-24 09:00AM	Envoy Medical Awarded Patent for Recharge System used with Implantable Battery (GlobeNewswire)
Aug-28-24 08:00AM	Envoy Medical Secures Lending Facility of $10M (GlobeNewswire)
Aug-12-24 08:34AM	Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update (GlobeNewswire) +19.47%
Jul-31-24 08:00AM	Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage (GlobeNewswire) +14.44%
Jul-01-24 08:00AM	Envoy Medical Announces Inclusion in the Russell Microcap Index (GlobeNewswire)
Jun-11-24 08:00AM	Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling (GlobeNewswire) -5.32%
Jun-06-24 09:00AM	Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index (GlobeNewswire)
Jun-05-24 08:00AM	Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology (GlobeNewswire) -7.93%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Patel Mona Chetan	Director	Feb 12 '26	Buy	0.40	312,500	125,000	332,500	Feb 17 04:51 PM
Potashnick Robert	Interim CFO	Feb 12 '26	Buy	0.40	212,500	85,000	212,500	Feb 17 04:49 PM
Kantor Susan	Director	Feb 12 '26	Buy	0.40	96,150	38,460	174,037	Feb 17 04:47 PM
BRYNELSEN CHARLES	Director	Feb 12 '26	Buy	0.40	1,000,000	400,000	1,050,000	Feb 17 04:45 PM
Lucas Brent T.	Chief Executive Officer	Feb 12 '26	Buy	0.40	62,500	25,000	297,090	Feb 17 04:45 PM
TAYLOR GLEN A	10% Owner	Feb 12 '26	Buy	0.40	18,750,000	7,500,000	21,703,607	Feb 17 01:35 PM

Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. It focuses on designing, developing, and marketing fully implantable medical devices that improve hearing. The company was founded in 1995 and is headquartered in White Bear Lake, MN.

CEO & DirectorMr. Brent T. Lucas Esq.

Chief Accounting OfficerMr. Robert M. Potashnick

VPMs. Karin Simonson

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COCH

Envoy Medical Inc

Upgrade your Finviz experience